Zhixi Su

3.2k total citations
74 papers, 1.3k citations indexed

About

Zhixi Su is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Zhixi Su has authored 74 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 21 papers in Cancer Research and 15 papers in Genetics. Recurrent topics in Zhixi Su's work include Cancer Genomics and Diagnostics (17 papers), Genomics and Phylogenetic Studies (16 papers) and Epigenetics and DNA Methylation (14 papers). Zhixi Su is often cited by papers focused on Cancer Genomics and Diagnostics (17 papers), Genomics and Phylogenetic Studies (16 papers) and Epigenetics and DNA Methylation (14 papers). Zhixi Su collaborates with scholars based in China, United States and Australia. Zhixi Su's co-authors include Xun Gu, Xun Gu, Zhan Zhou, Yanwu Zeng, Zhongming Zhao, Yangyun Zou, Jingcheng Wu, Shuqing Chen, Xiaoqiu Huang and Jianmin Wang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Zhixi Su

72 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhixi Su China 18 918 235 188 184 184 74 1.3k
Kuo Ping Chiu Singapore 11 1.4k 1.5× 158 0.7× 183 1.0× 129 0.7× 290 1.6× 17 1.9k
Thomas Albert Germany 18 1.5k 1.6× 227 1.0× 248 1.3× 97 0.5× 143 0.8× 51 1.9k
Sumio Sugano Japan 15 1.3k 1.4× 193 0.8× 300 1.6× 133 0.7× 147 0.8× 25 1.7k
Arne H. Smits Netherlands 18 1.6k 1.7× 207 0.9× 212 1.1× 109 0.6× 121 0.7× 19 2.0k
Christian Jaulin France 18 755 0.8× 286 1.2× 138 0.7× 108 0.6× 84 0.5× 37 1.2k
Yan P. Yuan Germany 14 724 0.8× 168 0.7× 124 0.7× 128 0.7× 197 1.1× 23 1.2k
Yonghong Ren China 16 646 0.7× 616 2.6× 203 1.1× 195 1.1× 111 0.6× 23 1.6k
Hermann Ragg Germany 23 979 1.1× 326 1.4× 157 0.8× 309 1.7× 274 1.5× 46 1.6k
Chieri Tomomori‐Sato United States 19 1.9k 2.0× 124 0.5× 237 1.3× 223 1.2× 135 0.7× 24 2.3k
Darrin F. Taylor Australia 15 1.3k 1.5× 315 1.3× 192 1.0× 113 0.6× 235 1.3× 23 1.9k

Countries citing papers authored by Zhixi Su

Since Specialization
Citations

This map shows the geographic impact of Zhixi Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhixi Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhixi Su more than expected).

Fields of papers citing papers by Zhixi Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhixi Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhixi Su. The network helps show where Zhixi Su may publish in the future.

Co-authorship network of co-authors of Zhixi Su

This figure shows the co-authorship network connecting the top 25 collaborators of Zhixi Su. A scholar is included among the top collaborators of Zhixi Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhixi Su. Zhixi Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yuan, Huangbo, Yanfeng Jiang, Zhenqiu Liu, et al.. (2025). Leveraging biomarkers and primary care embedding for scalable precision cancer prevention in China: Insights from the FuSion study. The Innovation. 7(3). 101189–101189.
4.
Zhao, Danyang, Yiying Liu, Yuan Ji, et al.. (2024). Blood leukocytes as a non-invasive diagnostic tool for thyroid nodules: a prospective cohort study. BMC Medicine. 22(1). 147–147. 3 indexed citations
5.
Chen, Huang, Yiying Liu, Minjie Xu, et al.. (2024). MeIS: DNA Methylation-Based Immune Response Signatures for Thyroid Nodule Diagnostics. The Journal of Clinical Endocrinology & Metabolism. 109(9). 2210–2219. 2 indexed citations
6.
Zhang, Zhao, et al.. (2024). Global level of methylation in the sea lamprey (jawless vertebrate) genome is intermediate between invertebrate and jawed vertebrate genomes. Journal of Experimental Zoology Part B Molecular and Developmental Evolution. 342(5). 391–397.
7.
Zou, Yangyun, H. J. Yang, Jingqi Zhou, et al.. (2024). Anciently duplicated genes continuously recruited to heart expression in vertebrate evolution are associated with heart chamber increase. Journal of Experimental Zoology Part B Molecular and Developmental Evolution. 342(2). 106–114. 1 indexed citations
9.
Zhao, Renjia, Yanfeng Jiang, Yunzhi Zhang, et al.. (2023). Abstract 4194: The FuSion Project of Pan-Cancer Early Screening in Chinese– An integrative study by Fudan University and Singlera. Cancer Research. 83(7_Supplement). 4194–4194. 2 indexed citations
10.
Su, Ming‐Yang, Minjie Xu, Chengcheng Ma, et al.. (2023). Cross-platform comparisons for targeted bisulfite sequencing of MGISEQ-2000 and NovaSeq6000. Clinical Epigenetics. 15(1). 130–130. 6 indexed citations
11.
Wang, Zhoufeng, Zhe Li, Kun Zhou, et al.. (2021). Deciphering cell lineage specification of human lung adenocarcinoma with single-cell RNA sequencing. Nature Communications. 12(1). 6500–6500. 98 indexed citations
12.
Chen, Meng, Ran Wei, Gang Wei, et al.. (2021). Systematic evaluation of the effect of polyadenylation signal variants on the expression of disease-associated genes. Genome Research. 31(5). 890–899. 7 indexed citations
13.
Zhou, Jingqi, et al.. (2017). Paralog-Divergent Features May Help Reduce Off-Target Effects of Drugs: Hints from Glucagon Subfamily Analysis. Genomics Proteomics & Bioinformatics. 15(4). 246–254. 3 indexed citations
14.
Zhou, Zhan, Jingqi Zhou, Zhixi Su, & Xun Gu. (2014). Asymmetric Evolution of Human Transcription Factor Regulatory Networks. Molecular Biology and Evolution. 31(8). 2149–2155. 5 indexed citations
15.
Gu, Xun, Yangyun Zou, Zhixi Su, et al.. (2013). An Update of DIVERGE Software for Functional Divergence Analysis of Protein Family. Molecular Biology and Evolution. 30(7). 1713–1719. 160 indexed citations
16.
Zou, Yangyun, Zhixi Su, Jian Yang, Yanwu Zeng, & Xun Gu. (2009). Uncovering genetic regulatory network divergence between duplicate genes using yeast eQTL landscape. Journal of Experimental Zoology Part B Molecular and Developmental Evolution. 312B(7). 722–733. 6 indexed citations
17.
Su, Zhixi & Xun Gu. (2008). Predicting the Proportion of Essential Genes in Mouse Duplicates Based on Biased Mouse Knockout Genes. Journal of Molecular Evolution. 67(6). 705–709. 16 indexed citations
18.
Xu, Lin, Zhixi Su, Zhenglong Gu, & Xun Gu. (2008). Evolution of RNases in leaf monkeys: Being parallel gene duplications or parallel gene conversions is a problem of molecular phylogeny. Molecular Phylogenetics and Evolution. 50(2). 397–400. 8 indexed citations
19.
Su, Zhixi, Yong Huang, & Xun Gu. (2007). Tissue-driven Hypothesis with Gene Ontology (GO) Analysis. Annals of Biomedical Engineering. 35(6). 1088–1094. 8 indexed citations
20.
Su, Zhixi, et al.. (2005). Evolution of alternative splicing after gene duplication. Genome Research. 16(2). 182–189. 125 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026